Enanta Pharmaceuticals

ENTA • NASDAQ • Stock Fundamentals

Enanta Pharmaceuticals is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Jay R. Luly, with a market cap of $405.6M.

Market Cap$405.6M

Employees145.0

CEOJay R. Luly

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsMay 11, 2026 · 17 days agoQ1 2026

Next EarningsAug 10, 2026 · in 2 monthsQ2 2026

Financials

Based on Q1 2026 filing

Common questions about Enanta Pharmaceuticals

Enanta Pharmaceuticals (ENTA) has a market capitalization of $405.6M and trades on NASDAQ.

Enanta Pharmaceuticals has approximately 145 employees.